News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
Presentation TCT India 2025 Use of Intracoronary Imaging Reinforced in ACS Presenter: Bhushan Bari July 26, 2025
News Daily News Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA Michael O'Riordan February 24, 2025
News Daily News BMJ Investigation Revives Questions About PLATO, Ticagrelor Todd Neale December 20, 2024
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI Michael O'Riordan March 31, 2023
News Opinion Conversations in Cardiology Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR? January 02, 2020
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Features Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option? Shelley Wood April 30, 2019
News Daily News Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD Michael O'Riordan January 03, 2019
News Conference News AHA 2018 T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI Shelley Wood November 11, 2018
News Daily News Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size Michael O'Riordan April 07, 2017
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Daily News STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis Yael L. Maxwell April 10, 2014
News Daily News AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab February 27, 2013